PHRM — Pharmather Holdings Balance Sheet
0.000.00%
- CA$18.15m
- CA$16.59m
- 52
- 12
- 54
- 33
Annual balance sheet for Pharmather Holdings, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.219 | 5.88 | 12.1 | 6.25 | 2.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.001 | 0.029 | 0.03 | 0.056 | 0.023 |
Prepaid Expenses | |||||
Total Current Assets | 0.22 | 5.94 | 12.2 | 6.31 | 2.34 |
Net Property, Plant And Equipment | — | 0.004 | 0.002 | 0.001 | 0 |
Long Term Investments | |||||
Total Assets | 0.22 | 5.94 | 12.2 | 6.31 | 2.59 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.016 | 0.176 | 0.33 | 0.892 | 0.253 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 0.016 | 0.361 | 0.33 | 0.892 | 0.253 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.204 | 5.58 | 11.8 | 5.42 | 2.34 |
Total Liabilities & Shareholders' Equity | 0.22 | 5.94 | 12.2 | 6.31 | 2.59 |
Total Common Shares Outstanding |